Log In
Print this Print this

Aezea, Cenersen sodium (Cenersen) (EL625)

  Manage Alerts
Collapse Summary General Information
Company Eleos Inc.
DescriptionAntisense oligonucleotide which targets p53
Molecular Target p53
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase I
Standard IndicationMyelodysplastic syndrome (MDS)
Indication DetailsTreat myelodysplastic syndrome (MDS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today